Cargando…
Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E
Neurologic disorders, mainly Guillain-Barré syndrome and Parsonage–Turner syndrome (PTS), have been described in patients with hepatitis E virus (HEV) infection in industrialized and developing countries. We report a wider range of neurologic disorders in nonimmunocompromised patients with acute HEV...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622229/ https://www.ncbi.nlm.nih.gov/pubmed/26490255 http://dx.doi.org/10.3201/eid2111.141789 |
_version_ | 1782397562497531904 |
---|---|
author | Perrin, H. Blasco Cintas, P. Abravanel, F. Gérolami, R. d'Alteroche, L. Raynal, J.-N. Alric, L. Dupuis, E. Prudhomme, L. Vaucher, E. Couzigou, P. Liversain, J.-M. Bureau, C. Vinel, J.-P. Kamar, N. Izopet, J. Peron, J.-M. |
author_facet | Perrin, H. Blasco Cintas, P. Abravanel, F. Gérolami, R. d'Alteroche, L. Raynal, J.-N. Alric, L. Dupuis, E. Prudhomme, L. Vaucher, E. Couzigou, P. Liversain, J.-M. Bureau, C. Vinel, J.-P. Kamar, N. Izopet, J. Peron, J.-M. |
author_sort | Perrin, H. Blasco |
collection | PubMed |
description | Neurologic disorders, mainly Guillain-Barré syndrome and Parsonage–Turner syndrome (PTS), have been described in patients with hepatitis E virus (HEV) infection in industrialized and developing countries. We report a wider range of neurologic disorders in nonimmunocompromised patients with acute HEV infection. Data from 15 French immunocompetent patients with acute HEV infection and neurologic disorders were retrospectively recorded from January 2006 through June 2013. The disorders could be divided into 4 main entities: mononeuritis multiplex, PTS, meningoradiculitis, and acute demyelinating neuropathy. HEV infection was treated with ribavirin in 3 patients (for PTS or mononeuritis multiplex). One patient was treated with corticosteroids (for mononeuropathy multiplex), and 5 others received intravenous immunoglobulin (for PTS, meningoradiculitis, Guillain-Barré syndrome, or Miller Fisher syndrome). We conclude that pleiotropic neurologic disorders are seen in HEV-infected immunocompetent patients. Patients with acute neurologic manifestations and aminotransferase abnormalities should be screened for HEV infection. |
format | Online Article Text |
id | pubmed-4622229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-46222292015-11-02 Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E Perrin, H. Blasco Cintas, P. Abravanel, F. Gérolami, R. d'Alteroche, L. Raynal, J.-N. Alric, L. Dupuis, E. Prudhomme, L. Vaucher, E. Couzigou, P. Liversain, J.-M. Bureau, C. Vinel, J.-P. Kamar, N. Izopet, J. Peron, J.-M. Emerg Infect Dis Synopsis Neurologic disorders, mainly Guillain-Barré syndrome and Parsonage–Turner syndrome (PTS), have been described in patients with hepatitis E virus (HEV) infection in industrialized and developing countries. We report a wider range of neurologic disorders in nonimmunocompromised patients with acute HEV infection. Data from 15 French immunocompetent patients with acute HEV infection and neurologic disorders were retrospectively recorded from January 2006 through June 2013. The disorders could be divided into 4 main entities: mononeuritis multiplex, PTS, meningoradiculitis, and acute demyelinating neuropathy. HEV infection was treated with ribavirin in 3 patients (for PTS or mononeuritis multiplex). One patient was treated with corticosteroids (for mononeuropathy multiplex), and 5 others received intravenous immunoglobulin (for PTS, meningoradiculitis, Guillain-Barré syndrome, or Miller Fisher syndrome). We conclude that pleiotropic neurologic disorders are seen in HEV-infected immunocompetent patients. Patients with acute neurologic manifestations and aminotransferase abnormalities should be screened for HEV infection. Centers for Disease Control and Prevention 2015-11 /pmc/articles/PMC4622229/ /pubmed/26490255 http://dx.doi.org/10.3201/eid2111.141789 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Synopsis Perrin, H. Blasco Cintas, P. Abravanel, F. Gérolami, R. d'Alteroche, L. Raynal, J.-N. Alric, L. Dupuis, E. Prudhomme, L. Vaucher, E. Couzigou, P. Liversain, J.-M. Bureau, C. Vinel, J.-P. Kamar, N. Izopet, J. Peron, J.-M. Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E |
title | Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E |
title_full | Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E |
title_fullStr | Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E |
title_full_unstemmed | Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E |
title_short | Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E |
title_sort | neurologic disorders in immunocompetent patients with autochthonous acute hepatitis e |
topic | Synopsis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622229/ https://www.ncbi.nlm.nih.gov/pubmed/26490255 http://dx.doi.org/10.3201/eid2111.141789 |
work_keys_str_mv | AT perrinhblasco neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT cintasp neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT abravanelf neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT gerolamir neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT dalterochel neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT raynaljn neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT alricl neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT dupuise neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT prudhommel neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT vauchere neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT couzigoup neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT liversainjm neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT bureauc neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT vineljp neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT kamarn neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT izopetj neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise AT peronjm neurologicdisordersinimmunocompetentpatientswithautochthonousacutehepatitise |